Medprio Life Sciences Private Limited
About Medprio Life Sciences Private Limited
Data last updated:
Medprio Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 09 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33111DL2015PTC277683. Its GSTIN is 07AAJCM6687M1ZL (Delhi).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vikas Aggarwal and Babita Bansal.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 26 Block A – 4 Sector – 13 Sunrise Apartment Rohini, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.29 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹2.75 Lakh (net margin 0.8%) and EBITDA of ₹7.88 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medprio Life Sciences Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 26 Block A – 4 Sector – 13 Sunrise Apartment Rohini, Delhi, India – 110085
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Medprio Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medprio Life Sciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Medprio Life Sciences Private Limited, buy the company report.
Financials of Medprio Life Sciences Private Limited
FY 2025 filings availableMedprio Life Sciences Private Limited reported revenue of ₹3.29 Cr (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 1% growth in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medprio Life Sciences Private Limited, buy the company report.
Board of directors of Medprio Life Sciences Private Limited
Medprio Life Sciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Aggarwal | Director | 09 Mar 2015 | 11 Years 7 Months | Current |
| Babita Bansal Also directs: KSKV Research and Technologies Private Limited | Director | 12 Oct 2017 | 9 Years 0 Months | Current |
| Nanu Ram Aggarwal | Director | 09 Mar 2015 | 11 Years 7 Months | Current |
Auditor
Medprio Life Sciences Private Limited is audited by S BANSAL & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S BANSAL & CO | FY 2019 | 000838N |
Shareholding
The shareholding of Medprio Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Medprio Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medprio Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medprio Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medprio Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCM6687M1ZL | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medprio Life Sciences Private Limited, buy the company report.
Recent activity
Medprio Life Sciences Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Babita Bansal ceased to be Additional Director on 27 Sep 2018.
Frequently asked questions
Medprio Life Sciences is an active private limited company based in Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 09 March 2015 (11+ years old) and is registered under CIN U33111DL2015PTC277683.
Medprio Life Sciences has 3 current directors:
- Vikas Aggarwal - Director
- Babita Bansal - Director
- Nanu Ram Aggarwal - Director
The latest financial statements of Medprio Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medprio Life Sciences is 07AAJCM6687M1ZL, registered in Delhi.
The CIN (Corporate Identification Number) of Medprio Life Sciences is U33111DL2015PTC277683. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medprio Life Sciences was incorporated on 09 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Babita Bansal ceased to be Additional Director on 27 Sep 2018. Babita Bansal was appointed as Director on 12 Oct 2017. Nanu Ram Aggarwal was appointed as Director on 09 Mar 2015. Medprio Life Sciences has 4 board changes on record in total.
The registered office of Medprio Life Sciences is at House No. 26 Block A – 4 Sector – 13 Sunrise Apartment Rohini, Delhi, India – 110085.
Medprio Life Sciences operates in the healthcare industry, in the medical equipment retail and distribution segment.
The compliance status of Medprio Life Sciences is compliant as of 09 August 2026. The company is actively filing with the Registrar of Companies.